Loomis, Sayles & Company
MD icon

Loomis, Sayles & Company’s Pediatrix Medical MD Stock Holding History

Loomis, Sayles & Company’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-104,667
Closed -$5.82M – 911
2018
Q1 		$5.82M Sell
104,667
-28,472
-21% -$1.56M 0.01% 515
2017
Q4 		$7.12M Sell
133,139
-3,861
-3% -$182K 0.01% 484
2017
Q3 		$5.91M Sell
137,000
-15,709
-10% -$747K 0.01% 504
2017
Q2 		$9.22M Sell
152,709
-65,685
-30% -$3.89M 0.02% 433
2017
Q1 		$15.2M Sell
218,394
-27,281
-11% -$1.89M 0.04% 328
2016
Q4 		$16.4M Sell
245,675
-55,917
-19% -$3.64M 0.04% 321
2016
Q3 		$20M Sell
301,592
-137,499
-31% -$9.4M 0.05% 259
2016
Q2 		$31.8M Buy
439,091
+49,527
+13% +$3.4M 0.09% 156
2016
Q1 		$25.2M Sell
389,564
-29,876
-7% -$1.98M 0.07% 202
2015
Q4 		$30.1M Buy
419,440
+3,521
+0.8% +$260K 0.08% 172
2015
Q3 		$31.9M Sell
415,919
-48,841
-11% -$3.94M 0.09% 167
2015
Q2 		$34.4M Buy
464,760
+489
+0.1% +$35.2K 0.09% 183
2015
Q1 		$33.7M Sell
464,271
-291
-0.1% -$20.2K 0.09% 192
2014
Q4 		$30.7M Buy
464,562
+60,744
+15% +$3.71M 0.09% 208
2014
Q3 		$22.1M Buy
403,818
+109,201
+37% +$6.2M 0.06% 270
2014
Q2 		$17.1M Sell
294,617
-9,953
-3% -$586K 0.05% 402
2014
Q1 		$18.9M Sell
304,570
-546,382
-64% -$31.8M 0.05% 371
2013
Q4 		$45.4M Sell
850,952
-41,402
-5% -$2.22M 0.14% 161
2013
Q3 		$44.8M Sell
892,354
-49,034
-5% -$2.39M 0.15% 155
2013
Q2 		$43.1K Buy
+941,388
New +$42.1M 0.15% 160

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company's MD Position: Q2 2018 in Review

Loomis, Sayles & Company sold out of Pediatrix Medical (MD) in Q2 2018, closing a stake of 104,667 shares — an estimated $5.82M sold.

Loomis, Sayles & Company first reported a position in MD in Q2 2013 and held it in 20 quarters. The position peaked at $45.4M in Q4 2013. 322 funds tracked by Wall St. Rank hold MD as of Q2 2018.

  • Loomis, Sayles & Company reported no remaining Pediatrix Medical position as of Q2 2018 after selling out during the quarter.
  • Loomis, Sayles & Company sold 104,667 Pediatrix Medical shares in Q2 2018, an estimated $5.82M.
  • Loomis, Sayles & Company first reported a position in Pediatrix Medical in Q2 2013 and held it in 20 quarters.
  • Loomis, Sayles & Company's Pediatrix Medical position peaked at $45.4M in Q4 2013.
  • 322 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2018.

Based on Loomis, Sayles & Company's 13F filing for Q2 2018, filed 14 Aug 2018.